Driehaus Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB
Driehaus Capital Management's HZNP Position: Q4 2023 in Review
Driehaus Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 79,242 shares — an estimated $9.17M sold.
Driehaus Capital Management first reported a position in HZNP in Q4 2013 and held it in 21 quarters. The position peaked at $18M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.
- Driehaus Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Driehaus Capital Management sold 79,242 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $9.17M.
- Driehaus Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 21 quarters.
- Driehaus Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $18M in Q1 2023.
- 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.
Based on Driehaus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.